Wed, Apr 23, 2014, 9:51 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Apricus Biosciences, Inc. Message Board

  • slugg_n.snail slugg_n.snail Feb 1, 2013 9:01 AM Flag

    Feb is here,,, VITAROS launch and new CEO any minute now

    Cuz I Know !!!

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I HATE this Company and Stock... They have a potentially great product (s), but seem not to know how to market or sell it. Every they build up expectations of some great announcement it ends up being a let down .... and then there is the slam public offering after the share price was "finally" becoming decent.... all this launch any time BS is just that. I have NO faith in the Management here... how can't they have a world beater in both Vitaros and Femprox for so long and almost NO ONE knows about it ??? I lost my shirt on this one and even though the share price is low (and moving up today) I doubt it will be maintained and will probably come right back down and sit there.... then there's the #$%$ Damag (or Damage or whatever).... I wish I'd never heard of this company.... you can go long on this one... but you'll be in a wheel chair before this makes a good return -- if they don't go belly up first.

      Sour Grapes... I'm not short (or long)... just venting.. don't own one share anymore... but watched $30,000 disappear overnight and the share price has been in the dumps for a long long time since then.... The "ONLY" potential here is the long shot that someone buys them out... I'm not willing to put any eggs in that basket.

      Good luck to you believers.... if you get rich on this one I'm happy for you.

 
APRI
2.38-0.02(-0.83%)Apr 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.